Operational Survival Deficit of Neoadjuvant Chemotherapy in Early-Stage Breast Cancer: A Target Trial Emulation and Causal Machine Learning Study

Data Availability

The data underlying this article were provided by the Surveillance, Epidemiology, and End Results (SEER) Program (https://seer.cancer.gov) under the Surveillance Research Program, National Cancer Institute. The data is publicly available upon request and submission of a signed Data-Use Agreement to the SEER program.

https://seer.cancer.gov/data/